Northern Gritstone has led a £4 million seed investment in Sheffield University spinout Exciting Instruments alongside co-investors Empirical Ventures, NPIF II - Praetura Equity Finance, and serial entrepreneurs Stan Boland and Jonathan Millner.

Chiron Health AI, a health-tech startup which provides a breakthrough model in chronic disease management, has announced the successful completion of its pre-seed funding round, led by SFC Capital. The funding will enable Chiron Health AI to accelerate the launch of its fully integrated B2B product for healthcare payers, providers and pharma, and to develop a new data-driven self-care pathway designed to sit alongside medical care.

Little Journey, the healthtech company transforming the delivery of paediatric care through personalised psychological support, has raised £6m in Series A funding round. Mercia Ventures invested alongside the Northern Powerhouse Investment Fund I (NPIF I), Par Equity, Octopus Ventures, Calm/Storm Ventures, and angel investors.

MintNeuro, a pioneer of scalable, low-power semiconductor technology for minimally-invasive neural implant applications, has raised £1 million in a funding round led by Empirical Ventures. Additional investment came from Parkwalk Advisors (through the Imperial College Enterprise Fund), Imperial College London, Plug & Play, Excellis Holding, and several prominent angel investors.

Research Grid, the AI startup that helps medical research institutions automate back-office admin for clinical trials, has raised a $6.5m seed round. The company will use the new funding to double down on its mission of making clinical trials faster and more successful.

LaennecAI, a pioneering medical AI company based in Cardiff,has announced the successful completion of its pre-seed funding round. The company has secured investment from SFC Capital and OVC Ventures, along with grant funding from the Welsh Government, Innovate UK, and the National Institute for Health Research (NIHR). This combined support will accelerate the development of LaennecAI's software that turns every smartphone into an advanced digital stethoscope, aiming to bring healthcare closer to patients and usher in a new era of self-care

ReneuralTM has raised £200K in a pre-seed funding round led by SFC Capital, with an additional £275K in support from Innovate UK.  Reneural Technologies Limited, formerly known as CardioCrown, is addressing the critical gap in effective and continuous rehabilitation for stroke survivors with its innovative approach to enhance patient outcomes, reduce clinician burnout, and lowes healthcare costs. The company facilitates early discharge from hospitals, improves patient engagement and compliance, while enabling efficient remote care.

Scalpel AI, a London-based medtech transforming the management of surgical tools and implants using computer vision, has raised £3.8m ($4.8m) in a funding round led by Mercia Ventures, with participation from Tensor Ventures and private investors.  The investment will enable Scalpel AI to scale its global operations and roll out its technology with major players in the healthcare supply chain, including sterile services, hospitals, and prominent third-party logistics (3PL) services such as GlobalMed Logistix (GMLx).

FRANCE: Aenitis Technologies, a pioneer in acoustic-based cell manipulation, has successfully closed its equity financing with the European Innovation Council Fund advised by the European Investment Bank, Quadrivium I fund managed by Seventure Partners, Mifani Invest, Stamos, Weaving Invest, a few business angels and the company founders, marking a significant milestone in the deeptech sector. The funding, secured in a two stage round, will drive the company's innovative acoustofluidic technology towards commercial launch and global expansion.

Siloton, the Bristol-based health technology start-up, has secured £860,000 to progress the commercial roll-out of its groundbreaking eye imaging chip technology, which could help address the UK’s most common cause of sight loss.

Shift Bioscience is a biotech company using generative AI models to understand how activation of different genes can reverse the aging process. This research is a fundamental step forward in designing more effective drugs to treat age-related diseases. The company has announced that it has raised $16M (£12.5M) in Seed funding, led by BGF, with existing investors F-Prime Capital, Kindred Capital, and Jonathan Milner participating.

Kaydiar, a Welsh business using pioneering technologies to create an innovative range of footcare products has received the backing of a group of angel investors, along with the Development Bank of Wales, the Welsh Government, University of Wales Trinity St David and Innovate UK.